aDepartment of Preventive Medicine, Wonju College of Medicine, Yonsei University, Seoul, Korea
bSOS in Biochemistry, Jiwaji University, Gwalior, Madhya Pradesh, India
cSchool of Life Sciences, Sambalpur University, Jyoti Vihar, Burla, Odisha, India
© 2014 Published by Elsevier B.V. on behalf of Korea Centers for Disease Control and Prevention.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Male (n = 504), n (%) | Female (n = 196), n (%) | Difference (95% CI)a | |
---|---|---|---|
Metabolic syndrome | |||
Absent | 297 (59) | 82 (41.8) | |
Present | 207 (41) | 114 (58.2) | p < 0.05 |
Hypertensionb | |||
Absent | 226 (44.8) | 112 (57.1) | |
Present | 278 (55.2) | 84 (42.9) | 7.8 (3.739, 11.861)** |
Dyslipidemiac | |||
Absent | 220 (43.6) | 55 (28) | |
Present | 284 (56.3) | 141 (72) | 9 (−5.34, 23.34) |
Age group (y) | Coded value in dataseta |
Metabolic syndrome |
Odds of syndrome | Odds ratio compared to baseline group | |
---|---|---|---|---|---|
Yes | No | ||||
25–34 | 0 | 2 | 9 | 0.22 | 1 |
35–44 | 1 | 35 | 49 | 0.71 | 3.27 |
45–54 | 2 | 121 | 148 | 0.81 | 3.68 |
55–64 | 3 | 106 | 100 | 1.06 | 4.81 |
>65 | 4 | 57 | 73 | 0.78 | 3.5 |
a Relative prevalence (with 95% confidence interval). Hypertension: systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg or use of oral antihypertensive medication. Dyslipidemia: triglyceride ≥150 mg/dL or high density lipoprotein-cholesterol (HDL-C)< 0.9 mM in men or < 1.0 mM in women.
The Impact of BMI Categories on Metabolic Abnormality Development in Chinese Adults Who are Metabolically Healthy: A 7-Year Prospective Study